Zobrazeno 1 - 10
of 94
pro vyhledávání: '"Gustavo A Viani"'
Autor:
Agostinho Caleman Neto, Lucas T Rasmussen, Roger W de Labio, Valdeir F de Queiroz, Marília de AC Smith, Gustavo A Viani, Spencer LM Payão
Publikováno v:
Journal of Venomous Animals and Toxins including Tropical Diseases, Vol 20, Iss 0 (2014)
Background : Epidemiological investigations have indicated thatHelicobacter pyloriinduces inflammation in the gastric mucosa regulated by several interleukins. The genesIL1BandIL8are suggested as key factors in determining the risk of gastritis. The
Externí odkaz:
https://doaj.org/article/6314619376a94849a402daa8105a6bf6
Autor:
Maria Thereza Mansur Starling, Stephane Thibodeau, Cecília Félix Penido Mendes de Sousa, Felipe Cicci Farinha Restini, Gustavo A. Viani, Andre G. Gouveia, Lucas C. Mendez, Gustavo Nader Marta, Fabio Ynoe Moraes
Publikováno v:
Cancers, Vol 16, Iss 3, p 539 (2024)
The global cancer burden, especially in low- and middle-income countries (LMICs), worsens existing disparities, amplified by the rising costs of advanced treatments. The shortage of radiation therapy (RT) services is a significant issue in LMICs. Ext
Externí odkaz:
https://doaj.org/article/20feffad06fd464490972ae55bad22e0
Autor:
Samir Abdallah Hanna, Andre Guimaraes Gouveia, Fabio Ynoe Moraes, Arthur Accioly Rosa, Gustavo Arruda Viani, Adriano Massuda
Publikováno v:
The Lancet Regional Health. Americas, Vol 14, Iss , Pp 100333- (2022)
Summary: Background: The Radiotherapy Expansion Plan for Brazil's Unified Health System (PER-SUS) was an innovative program designed by the Ministry of Health in 2012 to provide improvements to the challenging problem of access to radiotherapy in the
Externí odkaz:
https://doaj.org/article/b8d04f2972774718816197a50b188251
Autor:
Gustavo A. Viani, Andre G. Gouveia, Ianara N.S.B. Silva, Gustavo S. Fernandes, Fabio Y. Moraes
Publikováno v:
International Journal of Radiation Oncology*Biology*Physics. 116:413-420
Autor:
Gustavo A, Viani, Andre G, Gouveia, Fernando K, Matsuura, Alexandre A, Jacinto, Fabio Y, Moraes
Publikováno v:
Radiotherapy and Oncology. 173:41-48
Assess Once daily (OD) chemoradiation effectiveness for LS-SCLC compared with twice daily (BID) chemoradiation.Following the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guideline, eligible randomized clinical trials (R
Autor:
Gustavo A. Viani, Andre G. Gouveia, Juliana F. Pavoni, Alexander Vicent Louie, Jay Detsky, Daniel E. Spratt, Fabio Y. Moraes
Publikováno v:
Clinical Oncology.
Autor:
Gustavo Arruda, Viani, Andre Guimaraes, Gouveia, Elton Trigo Teixeira, Leite, Fabio Ynoe, Moraes
Publikováno v:
Radiotherapy and Oncology. 171:7-13
To assess the effectiveness and safety of HYPO-SRT in patients with biochemical recurrence after radical prostatectomy, we performed a cohort study followed by meta-analysis (MA).A cohort study followed by a MA was designed to evaluate the biochemica
Autor:
Gustavo A Viani, Andre G Gouveia, Vanessa F Bratti, Juliana F Pavoni, Richard Sullivan, Wilma M Hopman, Christopher M Booth, Ajay Aggarwal, Timothy P Hanna, Fabio Y Moraes
Publikováno v:
The Lancet Oncology. 23:531-539
Similarly to several other upper-middle-income countries, there is a major shortfall in radiotherapy services for the treatment of cancer in Brazil. In this study, we developed the linear accelerator (LINAC) shortage index to assess the LINAC shortag
Publikováno v:
Radiotherapy and Oncology. 165:135-141
Objectives The management of Optic Nerve Sheath Meningiomas (ONSM) has suffered a significant shift due to new radiation techniques. However, there is no conclusive information on which approach presents better results in the literature. This meta-an
Autor:
Juliana Fernandes Pavoni, Alexander V. Louie, Gustavo Arruda Viani, Andre G. Gouveia, Martin Korzeniowski, Fabio Y. Moraes, Ana Carolina Hamamura
Publikováno v:
Repositório Institucional da USP (Biblioteca Digital da Produção Intelectual)
Universidade de São Paulo (USP)
instacron:USP
Universidade de São Paulo (USP)
instacron:USP
Objectives Stereotactic ablative radiotherapy (SABR) has been reported to be an effective treatment for oligometastatic disease from different primary cancer sites. Here we assess the effectiveness and safety of SABR for oligometastatic breast cancer